Analysts today predicted that GlaxoSmithKline will restart its multi-billion pound share buy-back scheme after it raised $1.7 billion selling its stake in US blood testing firm Quest Diagnostics... more
Shares in GlaxoSmithKline fall nearly 2%, or 22p, to 1151p, after Britain's biggest drugmaker calls off late-stage development on insomnia drug Almorexant... more
American pharmaceuticals worker who shopped manufacturing failures at GlaxoSmithKline’s factory in Puerto Rico is rewarded with a $96 million payout... more
GlaxoSmithKline hit by an embarrassing blow to its reputation when Britain's drug regulator said its diabetes medicine Avandia should be pulled from sale... more
Glaxo swallows a £1.57 billion charge to settle legal wrangles including litigation over its diabetes drug Avandia, after winning a reprieve over a safety scandal... more
Stephen Hester has been making the rounds of the big City institutions and the word is that the Royal Bank of Scotland boss is far more optimistic in private than he has been in public... more
Analysis: Convenient timing? Just before posting eye-wateringly high profit, GlaxoSmithKline announces plans to slash the cost of medicine to the world's poorest people... more
The needle-phobe's nightmare may be over after GlaxoSmithKline signed a £105 million joint venture that could see the end of the injected vaccine... more
GlaxoSmithKline, the drug company producing the bulk of Britain’s swine flu vaccine, said third-quarter pre-tax profit soared 23% to £1.91 billion as the firm cashed in from a boost in emerging markets and H1N1 drugs ... more
GlaxoSmithKline announced it had started to dispatch its swine flu vaccine around the world and said it has received contracts for 440 million doses of its pandemic vaccine ... more
GlaxoSmithKline is set to cash in on £1.8 billion from the rush for its swine flu vaccine, after nine more governments gave the pharma giant orders for another 96 million doses ... more
Pharma giant GlaxoSmithKline had a double injection of health, when the World Health Organisation approved its cervical cancer vaccine Cervarix and the British medical watchdog said it would reconsider its block on breast cancer treatment Tyverb’s use in the National Health Service... more
British drug giant GlaxoSmithKline received a boost today after research into its cervical cancer vaccine Cervarix showed it is the only treatment to protect against five of the most common viruses associated with the disease ... more
Britain's biggest pharmaceuticals giant GlaxoSmithKline today set up a joint venture with Shenzhen Neptunus to develop influenza vaccines for China ... more
Pharma giant GlaxoSmith Kline was today given a boost when the World Health Organisation endorsed its vaccine against a diarrhoea-causing virus that kills 500,000 children every year ... more
A dirty-brown brick building close to Northern Line station Mill Hill East is an unlikely place to find the saviour of the pharmaceuticals industry... more
The UK’s biggest pharmaceuticals firm, GlaxoSmithKline, blamed competition from American generic drugs as its first-quarter pre-tax profit fell 1.5% to £1.93 billion... more
Shire has struck a deal with GlaxoSmithKline, the world's second largest drugs group, to co-promote its hyperactivity medicine Vyvanse in the United States, sending its shares sharply higher... more
Exclusive: After high-profile allegations this season, Charlton's manager is pleased the issue is now being addressed but says the authorities still have plenty of work to do
Morning:
8°c
